The PREVENT research programme-A novel research programme to identify and manage midlife risk for dementia: The conceptual framework

International Review of Psychiatry

Volumn 25, Issue 6, 2013, Pages 748-754

  Ritchie, Craig W ^a,b   Wells, Katie ^a   Ritchie, Karen ^a,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WEST LONDON MENTAL HEALTH NHS TRUST   (United Kingdom)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BETA SECRETASE; SYNAPTOPHYSIN;

ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; COGNITIVE DEFECT; CONCEPTUAL FRAMEWORK; DEMENTIA; ENVIRONMENTAL FACTOR; HEREDITY; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; RISK MANAGEMENT; RISK REDUCTION; SYMPTOMATOLOGY;

DEMENTIA; FEMALE; HUMANS; MIDDLE AGED; PRODROMAL SYMPTOMS; PROGRAM DEVELOPMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 84892692906     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261.2013.869195     Document Type: Article

References (38)

1. Artero, S., Tierney, M.C., Touchon, J. & Ritchie, K. (2003). Prediction of transition from cognitive impairment to senile dementia: A prospective, longitudinal study. Acta Psychiatrica Scandinavic a, 107, 390-393.
2. Bateman, R.J., Xiong, C., Benzinger, T.L.S., Fagan, A.M., Goate, A., Fox, N.C.,... Morris, J.C. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer's disease. New England Journal of Medicine, 367, 795-804.
3. BISQ. (2011). Brain Injury Screening Questionnaire. New York: Brain Injury Research Center, Department of Rehabilitation Medicine, Mount Sinai Medical Center.
4. Borson, S., Frank, L., Bayley, P.J., Boustani, M., Dean, M., Lin, P.J.,... Ashford, J.W. (2013). Improving dementia care: The role of screening and detection of cognitive impairment. Alzheimer's Dementia, 9, 151-159.
5. Bosch, J., Yusuf, S., Pogue, J., Sleight, P., Lonn, E., Rangoonwala, B.,... Probstfield, J. (2002). Heart outcomes prevention evaluation. Use of ramipril in preventing stroke: Double blind randomised trial. British Medical Journal, 324, 699-702.
6. Brayne, C. & Davis, D. (2013). Making Alzheimer's disease and Dementia research fit for populations. Lancet, 381(9866), 533-534.
7. Buysse, D.J., Reynolds, C.F., Monk, T.H., Berman, S.R. & Kupfer, D.J. (1989). The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric research and practice. Psychiatry Research, 28, 193-213.
8. Connor, K.M. & Davidson, J.R. (2001). Connor-Davidson Resilience Scale (CD-RISC). Durham, NC: Duke University Medical Center.
9. Department of Health. (2013) Policy: Improving care for people with dementia. www.gov.uk/government/policies/improvingcare- for-people-with- dementia.
10. Fitzpatrick, A.L., Kuller, L.H., Lopez, O.L., Diehr, P., O'Meara, E.S., Longstreth, W.T. Jr & Luchsinger, J.A. (2009). Mid and late-life obesity: Risk of dementia in the cardiovasucular cognition study. Archives of Neurology, 66, 336-342.
11. Fox, N., Warrington, E. & Rossor, M. (1999). Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet, 353, 2125-2136.
12. Fratiglioni, L., Launer, L.J., Andersen, K., Breteler, M.M., Copeland, J.R., Dartigues, J.F.,... Hofman, A. (2000). Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology, 54(11 suppl. 5), S10-15.
13. Gandy, S. (2005). The role of cerebral amyloid βaccumulation in common forms of Alzheimer disease. Journal of Clinical Investigation, 115, 1121-1129.
14. Hulette, C.M., Welsh-Bohmer, K.A., Murray, M.G., Saunders, A.M., Mash, D.C. & McIntyre L.M. (1998). Neuropathological and neuropsychological changes in ' normal'aging; evidence for pre-clinical Alzheimer's disease in cognitively normal individuals. Journal of Neuropathology and Experimental Neurology, 57, 1168-1174.
15. Jack, C.R. Jr, Knopman, D.S., Jaqust, W.J., Peterson, R.C., Weiner, M.W., Aisen, P.S. & Trojanowski, J.Q. (2013). Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurology, 12, 207-216.
16. Kmietowicz, Z. (2012). Cameron launches challenge to end ' national crisis'of poor dementia care. British Medical Journal, 344, e2347.
17. Lambert, J.-C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A., Sims, R., Bellenguez C.,... Amouyel, P. (2013). Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature Genetics, doi:10.1038/ng.2802.
18. Le Couteur, D.G., Doust, J., Creasey, H. & Brayne, C. (2013). Political drive to screen for pre-dementia: Not evidence based and ignores the harms of diagnosis. British Medical Journal, 347, f5125.
19. Matthews, F.E., Arthur, A., Barnes, L.E., Bond, J., Jagger, C., Robinson L. & Brayne, C. (2013). A two decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: Results of the Cognitive Function and Ageing Study I and II. Lancet, 382 (9902), 1405-1412.
20. Milne, A. (2010). Dementia screening and early diagnosis: The case for and against. Health, Risk and Society, 12, 656-676.
21. Morris, M., Evans, D., Bienias, J., Tangney, C., Bennett, D., Aggarwal, N.,... Wilson, R. (2003). Dietary fats and the risk of incident Alzheimer disease. Archives of Neurology, 60, 194-200.
22. Morris, J. & Price, J. (2001). Pathologic correlates of nondemented aging, mild cognitive impairment and early stage Alzheimer's disease. Journal of Molecular Neuroscience, 17, 101-118.
23. Olichney, J.M., Yang, J.-C., Taylor, J. & Kutas, M. (2011). Cognitive event-related potentials: Biomarkers of synaptic dysfunction across the stages of Alzheimer's disease. Journal of Alzheimer's Disease, 26, 215-228.
24. Ott, A., Stolk, R.P., van Harskamp, F., Pols, H.A., Hofman, A. & Breteler, M.M. (1999). Diabetes mellitus and the risk of dementia: The Rotterdam study. Neurology, 53, 1937-1942.
25. Parra, M.A., Abrahams, S., Logie, R.H., Mendez, L.G., Lopera, F. & Della Sala, S. (2010). Visual short-term memory binding deficits in familial Alzheimer's disease. Brain, 133, 2702-2713.
26. Perrin, R.J., Craig-Schapiro, R., Malone, J.P., Shah, A.R., Gilmore, P., Davis, A.E.,... Fagan, A.M. (2011). Identifi- cation and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLOS ONE, 6, e16032.
27. Radloff, L.S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
28. Ravenni, R., Jabre, J. & Mazza, A. (2011). Primary stroke prevention and hypertension treatment: Which is the first-line strategy Neurology International, 3, e12.
29. Ritchie, K. (1988). The screening of cognitive impairment in the elderly: A critical review of current methods. Journal of Clinical Epidemiology. 41, 635-643.
30. Ritchie, K., Artero, S. & Touchon, J. (2001). Classification criteria for mild cognitive impairment: A population-based validation study. Neurology, 56, 37-42.
31. Ritchie, K., Carriére, I., Ritchie, C.W., Berr, C., Artero, S. & Ancelin, M.-L. (2010). Designing prevention programmes to reduce incidence of dementia: Prospective cohort study of modifiable risk factors. British Medical Journal, 341, c3885.
32. Ritchie, K. & Ritchie, C.W. (2012). The PREVENT study: A prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease. BMJ Open, 2 (6), e001893.
33. Scottish Collaborative Group. (2004). Food Frequency Questionnaire. Aberdeen: University of Aberdeen.
34. Sofi, F., Macchi, C., Abbate, R., Gensini, G.F. & Casini, A. (2012). Effectiveness of the Mediterranean diet: Can it help delay or prevent Alzheimer's disease Journal of Alzheimer's Disease, 20 (3), 795-801.
35. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. & Roses, A.D. (1993). Apolipoprotein E: High-avidity binding to betaamyloid and increased frequency of type 4 allele in lateonset familial Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 90, 1977-1981.
36. Van de Flier, W.M. & Scheltens, P. (2005). Epidemiology and risk factors of dementia. Journal of Neurology, Neurosurgery and Psychiatry, 76, 2-7.
37. Wolfe, J. & Kimerling, R. (1997). Gender issues in the assessment of posttraumatic stress disorder. In J. Wilson & T.M. Keane (Eds), Assessing Psychological Trauma and PTSD (pp. 192-238 ). New York: Guilford.
38. Wang, J.Z., Xia, Y.Y., Grundke-Iqbal, I. & Iqbal, K. (2013). Abnormal hyperphosphorylation of tau: Sites, regulation, and molecular mechanism of neurofibrillary degeneration. Journal of Alzheimer's Disease, 33, S123-139.